Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 23, 88-95 (2024)
doi: https://doi.org/10.1038/d41573-024-00001-x
Updates & Corrections
-
Update 22 January 2024: Information on the financial performance of the new drugs approved and the characteristics of the reviews by the FDA has been added to the article, with an additional column in Table 1 and Figure 4.
-
Correction 22 March 2024: Daiichi Sankyo has been added as one of the companies sponsoring the development of patritumab deruxtecan in Table 4.